NEWTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...
***** ***** Final Fantasy X Character Analysis: Auron ***** ***** ===== = Table of Content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results